Radioligand Therapies and Imaging

Cancer care has traditionally relied on three pillars, but new approaches are needed due to its complexity. Radioligand imaging and therapy offer a promising strategy by using radioactive isotopes to target cancer cells. These isotopes act like light bulbs, highlighting cancerous areas for treatment. By combining different isotopes with special molecules, researchers aim to develop new therapies that minimize damage to healthy cells. This innovative approach could become a new pillar in cancer care.

What have been the traditional pillars of cancer care?

• Radiation, surgery, and targeted therapy

• Chemotherapy, immunotherapy, and surgery

• Immunotherapy, surgery, and radiation

• Surgery, chemotherapy, and radiation

Why are new pillars needed in cancer care?

• Because new technology is always better

• Because cancer is complex and not fully solved

• Because traditional methods are too expensive

• Because cancer is simple and easily solved

What is the purpose of radioligand imaging?

• To destroy cancer cells directly

• To replace traditional chemotherapy

• To illuminate cancer cells for better visualization

• To prevent cancer from spreading

What does an imaging radioisotope act like?

• A magnet

• A light bulb

• A mirror

• A camera

How do radioligand molecules target cancer cells?

• By targeting cells randomly

• By targeting cells with specific biomarkers

• By targeting all cells in the body

• By targeting only healthy cells

What is the goal of using therapeutic radioisotopes?

• To replace surgery

• To enhance the immune system

• To damage all cells equally

• To limit damage to healthy cells

What is the future goal for radioligand imaging and therapies?

• To replace all existing cancer treatments

• To become another pillar in cancer care

• To be used only for rare cancers

• To be discontinued

How are new radioligand therapies being developed?

• By avoiding the use of radioisotopes

• By focusing only on one type of cancer

• By mixing and matching molecules with different isotopes

• By using the same isotopes for all cancers